 Extracorporeal shock lithotripsy gallstones results follow-up patients study biliary shock lithotripsy gallstones Dornier Medical Systems Munich United May efficacy safety extracorporeal shock lithotripsy ESWL need adjunctive therapy ursodeoxycholic acid UDCA forty-one symptomatic patients gallstones mm diameter treatment week ESWL patients UDCA placebo treatment months patients underwent follow-up predetermined intervals protocol re-treatment fragments mm diameter weeks patients months stone-free rates single stones patients noncalcified stones UDCA patients noncalcified stones placebo patients stones UDCA placebo significant difference UDCA placebo groups months stone-free rates patients single noncalcified stones mm diameter UDCA placebo superior rates solitary noncalcified gallstones mm diameter stones